BBSI Posts Modest Q1 2026 Growth; HOLD Thesis Intact

What happened

BBSI reported Q1 2026 revenue of $307.0 million, up 5% year-over-year, and gross billings of $2.16 billion, up 3%. The results show steady but unspectacular growth, consistent with the company's historical trajectory. While revenue growth outpaced billings growth, suggesting a slight mix shift or pricing improvement, the overall pace remains moderate. The HOLD thesis from the DeepValue report is reinforced, as no new catalysts or risks have emerged to alter the balanced risk/reward profile. The stock continues to trade at a reasonable P/E (~16.7x) but a rich EV/EBITDA (~30.6x), leaving little room for error.

Implication

For long-term investors, the modest growth and stable execution support a hold, but the high EV/EBITDA and geographic concentration limit upside. The thesis hinges on margin improvement from favorable workers' comp trends, which have not yet materialized.

Thesis delta

No meaningful change. The Q1 results are in line with expectations and do not alter the HOLD thesis. The modest growth does not justify a BUY given the rich valuation, nor does it signal deterioration that would require a SELL. The watch items remain workers' comp loss experience and payroll volume growth.